The Balancing Act: Treatment Strategies and Safety

Treating an Inborn Error of Immunity (IEI) with autoinflammation is a delicate “balancing act.” Your medical team must use one set of tools to turn down your overactive immune system (immunosuppression) and another set to bolster your underactive defenses (immunoglobulin replacement and prophylaxis) ^[1][2].

Because these conditions are rare and heterogeneous, there is no “one-size-fits-all” protocol. Many treatments described below are used off-label based on case reports or small series, and specialists must create highly individualized plans based on your specific genotype ^[3][4].

Medication Safety Box

• Do not stop abruptly: Never stop taking prescribed corticosteroids (like prednisone) or immunosuppressants suddenly without your treating team’s guidance.
• Vaccinations: Obtain a subtype- and medication-specific vaccine plan. Live vaccines may be unsafe with particular immune defects or immunosuppression, and IVIG can affect vaccine interpretation.
• Infection Screening: Your doctor should screen for latent infections (like TB) before starting biologics or JAK inhibitors.

Managing Overactive Inflammation

When your innate immune system is in a flare, doctors use targeted medications to block specific signaling pathways.

• Glucocorticoids (Steroids): Medications like prednisone act quickly to “put out the fire” during a severe flare ^[5]. However, because of long-term side effects like bone thinning, cardiovascular risks, and increased infection risk, they are rarely used as a permanent solution ^[6].
• Targeted Biologics: These are engineered proteins that block specific inflammatory “messengers” (cytokines). Depending on genotype and phenotype, specialists may utilize TNF Inhibitors (e.g., in HA20) or IL-1 Inhibitors ^[7][4].
• JAK Inhibitors: These newer oral medications block a “hub” of inflammatory signals inside cells and may be considered in conditions like VEXAS or PRAAS. However, they carry important warnings for infections, blood clotting, and cardiovascular risks ^[8][6].

Protecting Against Underactive Defenses

If your doctor prescribes immunosuppressants without accounting for your immunodeficiency, the risk of life-threatening infection increases significantly ^[1]. To prevent this, two main strategies are used when clinically indicated:

1. Immunoglobulin Replacement Therapy (IRT): If you have a clinically meaningful antibody deficiency and a history of infections, doctors may infuse antibodies from healthy donors. This can be done via IVIG (intravenous) or SCIG (subcutaneous) ^[9][10]. This provides you with the “library” of antibodies your own system is missing ^[9].
2. Antimicrobial Prophylaxis: Depending on the exact immune defect and infection pattern, taking a low dose of an antibiotic, antiviral, or antifungal daily can prevent infections from taking hold. This must be weighed against adverse effects, resistance, and C. difficile infection ^[1].

Advanced and Curative Options

For severe cases that do not respond to standard medications, more intensive therapies may be considered by a specialist center.

• Azacitidine: In VEXAS syndrome, particularly when it is associated with a blood disorder called Myelodysplastic Syndrome (MDS), this medication is used as a hematology-directed treatment. It has been shown in observational cohorts to reduce inflammation and improve blood counts in a subset of patients, though it carries risks of infections and cytopenias and does not guarantee clearance of the mutated clone ^[11][12].
• Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): This procedure involves replacing the immune system with healthy donor cells ^[13]. It may be considered as a potentially curative option for selected severe inherited IEIs or highly refractory VEXAS cases. Because the procedure carries significant risks—including Graft-versus-Host Disease (GVHD) and severe infection—transplant decisions depend heavily on severity, organ damage, genotype, age, and donor options ^[14][15].

A Warning on Broad Immunosuppression

It is vital that your care is managed by a specialist. Doctors who are not familiar with these syndromes may mistakenly prescribe “broad” immunosuppressants without checking your antibody levels or monitoring for “opportunistic” infections ^[1]. Your treatment plan must always address both sides of your diagnosis simultaneously ^[1][16].